Xenetic Biosciences

Xenetic Biosciences

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$725
$660
$806
$766
Gross Profit
-1,739
660
806
766
EBITDA
-1,695
-929
-456
-579
EBIT
-971
-502
-623
Net Income
-1,695
-929
-456
-579
Net Change In Cash
725
660
806
766
Free Cash Flow
-662
-875
-536
-242
Cash
5,809
6,471
7,347
7,883
Basic Shares
2,343
2,294
2,291
2,291

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,976
$2,500
$2,539
$1,706
Gross Profit
2,976
2,500
2,539
1,706
EBITDA
-2,680
-3,806
-4,134
-6,525
EBIT
-2,834
-3,960
-4,487
-6,552
Net Income
-2,680
-3,960
-4,134
-6,552
Net Change In Cash
2,976
2,500
2,539
1,706
Free Cash Flow
-2,286
-2,817
-4,114
-5,146
Cash
7,883
6,165
8,983
13,097
Basic Shares
1,701
1,541
1,528
1,422

Earnings Calls

QuarterEPS
2026-09-30
-$0.72
2026-06-30
-$0.41
2026-03-31
-$0.19
2025-12-31
-$0.22